Autonomix Medical, Inc. (AMIX) - Dilution Analysis

10-K filing | 11.4M shares outstanding

S-1 filing: This S-1 filing from Autonomix Medical, Inc. relates to the offer and resale of up to 2,500,000 shares of common stock by Lincoln Park Capital Fund, LLC, consisting of Purchase Shares and Commitment Shares, with the company potentially receiving proceeds of up to $15.0 million from the sale of Purchase Shares.

S-1/A filing: This SEC filing discusses the terms and conditions related to the exercise of warrants, including compensation for failure to deliver warrant shares, limitations on beneficial ownership, and other related provisions.

S-1 filing: This is an S-1 filing containing information on the company's equity, restricted stock, common stock offerings, stock plans, stock options, license agreements, offering agreements, and equity-based stock warrants.

10-Q filing | 4.0M shares outstanding

8-K filing: Autonomix Medical, Inc. entered into a warrant exercise inducement offer letter with holders of existing warrants, reducing the exercise price in exchange for the exercise of warrants and issuance of new warrants. ($2.5M proceeds)

POS AM filing: This prospectus relates to 1,533,096 shares of common stock issuable upon the exercise of Series A warrants issued in the public offering we completed November 22, 2024 and an ATM Agreement.

10-K filing | 2.5M shares outstanding

S-3/A filing: This is an S-3/A filing made on 2025-03-07, detailing potential offerings of warrants and purchase contracts, with conditions for their issuance and sale.

S-3 filing: The company is filing an S-3 shelf registration to offer up to $200,000,000 of common stock, preferred stock, debt securities, warrants, purchase contracts, or units of securities.

10-Q filing | 2.5M shares outstanding

8-K filing: Autonomix Medical, Inc. closed a public offering on November 25, 2024, involving common units and pre-funded units, with Ladenburg Thalmann & Co. Inc. as the underwriter, resulting in gross proceeds of approximately $10.0 million. ($0.01M proceeds)

S-1/A filing: This S-1/A filing details a firm commitment public offering of common stock units and pre-funded warrant units, along with representative warrants, for Autonomix Medical, Inc.

10-Q filing | 1.1M shares outstanding

S-1 filing: This S-1 filing outlines a firm commitment public offering of common stock units and pre-funded warrant units, along with representative warrants.

8-K filing: Stock split 1-for-20 | Outstanding: 18,902,248 → 1,150,000

10-Q filing | 18.9M shares outstanding

8-K filing: Autonomix Medical, Inc. issued 250,000 shares of its common stock to RF Innovations, Inc. as consideration for a perpetual non-exclusive worldwide royalty free fully paid license related to the Licensed Products.

10-K filing | 18.8M shares outstanding

10-Q filing | 18.8M shares outstanding

8-K filing: On January 26, 2024, the Company completed its initial public offering and sold 2,234,222 shares of its common stock at a price to the public of $5.00 per share, resulting in aggregate gross proceeds of $11,171,110, before deducting selling agent commissions and other related expenses. ($11.17M proceeds)